Under-Reported Aspects of Platinum Drug Pharmacology
AbstractPlatinum drugs remain the backbone of many antineoplastic regimens. Among the numerous chemical or pharmacological effects of platinum drugs, some aspects tend to be under-reported. Thus, this perspective paper intends to stress some neglected properties of platinum drugs: first, the physico-chemical characteristics (aquation reaction kinetics) that determine site-specific toxicity; second, the impact on RNA molecules. Knowledge of the ‘RNA world’ has dramatically changed our understanding of cellular and molecular biology. The inherent RNA-crosslinking properties should make platinum-based drugs interact with coding and non-coding RNAs. Third, we will discuss the impact on the immune system, which is now recognized to substantially contribute to chemotherapy efficacy. Together, platinum drugs are in fact old drugs, but are worth re-focusing on. Many aspects are still mysterious but can pave the way to new drugs or an improved application of the already existing compounds. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Theile, D. Under-Reported Aspects of Platinum Drug Pharmacology. Molecules 2017, 22, 382.
Theile D. Under-Reported Aspects of Platinum Drug Pharmacology. Molecules. 2017; 22(3):382.Chicago/Turabian Style
Theile, Dirk. 2017. "Under-Reported Aspects of Platinum Drug Pharmacology." Molecules 22, no. 3: 382.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.